Many insurers and analysts have hailed IFRS 17 Insurance Contracts and IFRS 9 Financial Instruments as a positive accounting change, offering better comparability than IFRS 4 Insurance Contracts, aligning asset and liability measurement models and clearer presentation and disclosures in the financial statements. Some also believe that company valuations may increase over time due to the greater transparency under IFRS 17.
To consider insurers’ views in more detail, we have analysed information provided by 26 insurers across the globe on the potential impacts of IFRS 17 and IFRS 91. This information was shared as part of their investor education sessions and/or their quarterly or half-yearly reporting (where relevant).
Our analysis highlighted that insurers expect:
- IFRS 17 will have a significant impact but it is primarily an accounting change;
- accounting mismatches and related volatility in the income statement will be significantly reduced under IFRS 17 and IFRS 9; and
- the new standards will not affect a company’s strategy and its capacity to pay dividends.
What does our analysis show?
We set out our key insights in the table below. Our additional summary provides more detailed analysis on these and other areas.